X

Health Care

Avid Bioservices, Inc. (CDMO) Q1 2021 Earnings Call Transcript

Avid Bioservices, Inc.  (NASDAQ: CDMO) Q1 2021 earnings call dated Sep. 01, 2020 Corporate Participants: Tim Brons -- Investor Relations Nicholas Green -- President…

Aimmune Therapeutics Inc (AIMT) Q2 2020 Earnings Call Transcript

Aimmune Therapeutics Inc (NASDAQ: AIMT) Q2 2020 earnings call dated July 30, 2020   Corporate Participants: DeDe Sheel -- Vice President of…

Medtronic (MDT) revisits business strategy even as recovery gathers steam

https://www.youtube.com/watch?v=ukh0vaOtvBw For Medtronic plc (NYSE:MDT), the last two quarters were disappointing as healthcare institutions postponed routine medial procedures and channeled…

Will da Vinci power help Intuitive Surgical (ISRG) beat COVID blues?

Being part of a rapidly growing industry and having a successful business model can be a winning combination in difficult…

Medtronic PLC (MDT) Q1 2021 Earnings Call Transcript

Medtronic PLC (NYSE: MDT) Q1 2021 earnings call dated Aug. 25, 2020 Corporate Participants: Ryan Weispfenning -- Vice President, Investor Relations Geoffrey…

Should you buy Liminal BioSciences (LMNL) stock?

So far, COVID-19 has claimed more than 800,000 lives all over the world. The biomedical community is rigorously working on…

Medtronic (MDT) Earnings: 1Q21 Key Numbers

Medtronic plc (NYSE:MDT) reported first quarter 2021 earnings results today. Worldwide revenue decreased 13% to $6.5 billion. GAAP net income…

Stable demand should help PetMed (PETS) emerge stronger from pandemic

PetMed Express (NASDAQ: PETS) has been around for a long time, expanding its foothold in the lucrative pet care market…

Agilent Technologies Inc. (A) Q3 2020 Earnings Call Transcript

Agilent Technologies Inc  (NYSE: A) Q3 2020 earnings call dated Aug. 18, 2020 Corporate Participants: Ankur Dhingra -- Vice President of Investor…

CureVac (CVAC): Another COVID-19 stock that attracted investors

In recent times, investors have been betting on the biotech companies that are in the race to develop the COVID-19…

Veru Inc. (VERU) Q3 2020 Earnings Call Transcript

Veru Inc. (NASDAQ: VERU) Q3 2020 earnings call dated Aug. 13, 2020 Corporate Participants: Samuel Fisch -- Director, Investor Relations Mitchell Steiner -- Chairman,…

Is Altimmune (ALT) stock a buy right now?

A lot of stocks in the biotech space have skyrocketed this year after their announcements and advances in finding a…

Biocept Inc. (BIOC) Q2 2020 Earnings Call Transcript

Biocept Inc. (NASDAQ: BIOC) Q2 2020 earnings call dated Aug. 12, 2020 Corporate Participants: Jody Cain -- Investor Relations Michael W. Nall -- President…

Biocept (BIOC) revenue drops 23% in Q2; loss narrows

Biocept (NASDAQ: BIOC) reported a narrower loss in the second quarter of 2020. The company's revenue declined by 23% year-over-year…

Infographic: How SmileDirectClub (SDC) performed in Q2 2020

SmileDirectClub Inc. (NASDAQ: SDC) reported second quarter 2020 earnings results today. Total revenue was $107 million compared to $195 million…

Lemonade Inc. (LMND) Q2 2020 Earnings Call Transcript

Lemonade Inc. (NYSE: LMND) Q2 2020 earnings call dated Aug. 12, 2020 Corporate Participants: Yael Wissner-Levy -- Vice President, Communications Daniel Schreiber -- Co-Founder,…

Novavax (NVAX) stock tumbles despite beating bottom line estimates in Q2

After Novavax (NASDAQ: NVAX) reported its progress on developing the COVID-19 vaccine at the end of February, the shares of…

Aurinia Pharmaceuticals Inc. (AUPH) Q2 2020 Earnings Call Transcript

Aurinia Pharmaceuticals Inc  (NASDAQ: AUPH) Q2 2020 earnings call dated Aug. 11, 2020 Corporate Participants: Glenn Schulman -- Senior Vice President, Corporate…

10x Genomics, Inc. (TXG) Q2 2020 Earnings Call Transcript

10x Genomics, Inc.  (NASDAQ: TXG) Q2 2020 earnings call dated Aug. 11, 2020 Corporate Participants: Eric Jaschke -- Director of Investor Relations…

Inovio (INO) aims to produce 100 million doses of COVID-19 vaccine in 2021

Shares of INOVIO (NASDAQ: INO) were down over 23% on Tuesday, a day after the company reported second quarter 2020…

Trxade launches integrated COVID-19 risk assessment tool for corporate clients

Integrated drug procurement firm Trxade Group (NASDAQ: MEDS) on Tuesday launched a one-of-its-kind platform that brings together various services such…